Building Your Care Team: Preparing for the Road Ahead
At a Glance
Managing Progressive Supranuclear Palsy (PSP) requires a multidisciplinary care team led by a Movement Disorder Specialist. This team should include physical, occupational, and speech therapists, along with a neuro-ophthalmologist, to proactively manage symptoms and maintain independence.
Receiving a diagnosis of Progressive Supranuclear Palsy (PSP) is the beginning of a new chapter in your healthcare. Because this condition is rare and complex, your local doctor or even a general neurologist may not have the specialized experience needed to manage it effectively [1][2].
Building the right care team starts with finding a specialist who understands the “PSP profile” and can connect you to a network of therapists [1][3].
Why You Need a Movement Disorder Specialist
A Movement Disorder Specialist is a neurologist who has completed 1–2 years of additional fellowship training specifically in conditions like Parkinson’s and PSP [1].
- Accuracy: They are trained to use the 2017 MDS diagnostic criteria, the global “gold standard” for correctly identifying PSP and its subtypes [4][5].
- Efficiency: They can quickly recognize “red flags” (like early falls or gaze palsy) that a general neurologist might mistake for standard Parkinson’s disease [1][6].
- Connections: These specialists are more likely to be part of research networks and can refer you to clinical trials or specialized therapists who understand the disease’s unique challenges [1][7].
Your First Visit Checklist: What to Bring
The first visit with a specialist is often long and detailed. Being prepared ensures they have the data they need to confirm your diagnosis [2][5].
- The MRI Discs: Do not rely on just the printed report. Specialists need the actual digital images (often on a CD or via a portal) to look for subtle signs like the “hummingbird” profile [6][8].
- The Symptom Timeline: Bring a diary or log that lists when your first balance issues, falls, vision changes, or personality shifts began. This timeline is critical for distinguishing PSP from other conditions [8][9].
- Medication History: List every drug you’ve tried for Parkinson’s (like Levodopa), including the dose and whether it helped (even if only for a short time) [2][10].
The “Care Roster”: Your Essential Team
PSP affects many parts of the body, so you will eventually need a “roster” of specialists working together [2][5].
| Member | Role | Why They Matter |
|---|---|---|
| Movement Disorder Specialist | Lead Physician | Coordinates your diagnosis, medications, and clinical trial options [1]. |
| Physical Therapist (PT) | Mobility Expert | Focuses on balance training and safety to prevent dangerous backward falls [3]. |
| Speech-Language Pathologist (SLP) | Swallow & Voice Specialist | Monitors swallowing safety (dysphagia) and helps maintain communication skills [11]. |
| Neuro-ophthalmologist | Vision Specialist | Evaluates the specific eye movement disorders hallmark to PSP [9][12]. |
| Occupational Therapist (OT) | Independence Specialist | Helps modify your home environment and find tools for daily living [11]. |
| Palliative Care Specialist | Quality of Life Expert | Focuses on managing symptoms like pain, sleep, and mood throughout the journey [5][13]. |
By recruiting these specialists early, you ensure that you aren’t just reacting to symptoms, but proactively managing your health and independence [5][14].
Return to the Main Guide
Common questions in this guide
Why do I need a movement disorder specialist for PSP?
What should I bring to my first appointment for a suspected PSP diagnosis?
Which therapists are essential for a PSP care team?
How can a neuro-ophthalmologist help with PSP?
Related questions
Get notified when new evidence is published on Progressive supranuclear palsy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Disease course and treatment patterns in progressive supranuclear palsy: A real-world study.
Morgan JC, Ye X, Mellor JA, et al.
Journal of the neurological sciences 2021; (421()):117293 doi:10.1016/j.jns.2020.117293.
PMID: 33385754 - 2
Progressive supranuclear palsy, a case report.
Ortiz A, Troya F, de Vera J, Vázquez E
Archivos de la Sociedad Espanola de Oftalmologia 2024; (99(7)):304-308 doi:10.1016/j.oftale.2024.05.004.
PMID: 38768849 - 3
Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life.
Fabbri M, Ledda C, Schirinzi T, et al.
Parkinsonism & related disorders 2024; (125()):107047 doi:10.1016/j.parkreldis.2024.107047.
PMID: 38964017 - 4
Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
Ali F, Martin PR, Botha H, et al.
Movement disorders : official journal of the Movement Disorder Society 2019; (34(8)):1144-1153 doi:10.1002/mds.27619.
PMID: 30726566 - 5
Quality of life in patients with progressive supranuclear palsy: a review of literature and implications for practice.
Markiewicz M, Madetko-Alster N, Alster P
Frontiers in neurology 2024; (15()):1476488 doi:10.3389/fneur.2024.1476488.
PMID: 39634776 - 6
Methods and utility of quantitative brainstem measurements in progressive supranuclear palsy versus Parkinson's disease in a routine clinical setting.
Cooperrider J, Bluett B, Jones SE
Clinical parkinsonism & related disorders 2020; (3()):100033 doi:10.1016/j.prdoa.2020.100033.
PMID: 34316619 - 7
Emerging drugs for progressive supranuclear palsy.
Giagkou N, Stamelou M
Expert opinion on emerging drugs 2019; (24(2)):83-92 doi:10.1080/14728214.2019.1609450.
PMID: 31007097 - 8
Progressive supranuclear palsy as differential diagnosis of Parkinson's disease in the elderly.
Fernández-Ferreira R, García-Santos RA, Rodríguez-Violante M, et al.
Revista espanola de geriatria y gerontologia 2019; (54(5)):251-256 doi:10.1016/j.regg.2019.04.002.
PMID: 31324404 - 9
Progressive supranuclear palsy: A case report and brief review of the literature.
Batheja V, Fish M, Balar AB, et al.
Radiology case reports 2024; (19(1)):250-253 doi:10.1016/j.radcr.2023.09.012.
PMID: 38028282 - 10
Acute Levodopa Challenge in Atypical Parkinsonism: Comprehensive Analysis of Individual Motor Responses.
Ye L, Sani SS, Veith Sanches L, et al.
Brain sciences 2024; (14(10)) doi:10.3390/brainsci14100991.
PMID: 39452005 - 11
Clinical Approach to Progressive Supranuclear Palsy.
Ling H
Journal of movement disorders 2016; (9(1)):3-13 doi:10.14802/jmd.15060.
PMID: 26828211 - 12
Detecting Abnormal Eye Movements in Patients with Neurodegenerative Diseases - Current Insights.
Sekar A, Panouillères MTN, Kaski D
Eye and brain 2024; (16()):3-16 doi:10.2147/EB.S384769.
PMID: 38617403 - 13
Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis.
Rana AQ, Qureshi AR, Siddiqui O, et al.
Journal of neurology 2019; (266(9)):2093-2102 doi:10.1007/s00415-018-9049-7.
PMID: 30238268 - 14
PDQ-8: A Simplified and Effective Tool Measuring Life Quality in Progressive Supranuclear Palsy.
Li XY, Chen MJ, Liang XN, et al.
Journal of Parkinson's disease 2023; (13(1)):83-91 doi:10.3233/JPD-223553.
PMID: 36591660
This page is for informational purposes only and does not replace professional medical advice. Always consult your movement disorder specialist or healthcare team about your specific PSP care plan.